Company Filing History:
Years Active: 2018
Title: Jacques-Philippe Colletier: Innovator in Alzheimer's Treatment
Introduction
Jacques-Philippe Colletier is a notable inventor based in Grenoble, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for butyrylcholinesterase. His work is particularly relevant for the treatment of Alzheimer's disease and other forms of dementia.
Latest Patents
Colletier holds a patent for "Disubstituted piperidines as butyrylcholinesterase inhibitors." This invention relates to new inhibitors of butyrylcholinesterase with general formulas I and II, where substituents are described in the patent description. The compounds can exist as pure enantiomers, racemic mixtures, or in the form of pharmaceutically acceptable salts. The present invention emphasizes the use of these inhibitors for treating Alzheimer's disease and other forms of dementia. He has 1 patent to his name.
Career Highlights
Throughout his career, Colletier has worked with various institutions, including the University of Ljubljana. His research has focused on developing innovative solutions to complex medical challenges, particularly in neurodegenerative diseases.
Collaborations
Colletier has collaborated with notable individuals in his field, including Boris Brus and Urban Kosak. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Jacques-Philippe Colletier is a prominent figure in the realm of pharmaceutical innovation, particularly in the fight against Alzheimer's disease. His contributions through his patent and collaborations highlight his commitment to improving healthcare solutions.